Pure­spring nabs $105M to take gene ther­a­py in­to the clin­ic as IgAN field ma­tures

Pure­spring Ther­a­peu­tics has reeled in £80 mil­lion ($105 mil­lion) to test two gene ther­a­pies in hu­mans.

The Sofinno­va Part­ners-led Se­ries B, dis­closed Wednes­day morn­ing, will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER